| |
| |
|
| Insider
Information: |
Cormorant Private Healthcare Fund Iii Lp |
| Relationship: |
10% Owner |
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
10 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
20,746,557 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$458,053,117 |
|
|
| Total
Shares |
20,746,557 |
|
|
| Total
Value |
$458,053,117 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Olema Pharmaceuticals, Inc. |
OLMA |
10% Owner |
2020-11-23 |
0 |
2020-11-23 |
3,270,544 |
Premium* |
|
|
Prometheus Biosciences, Inc. |
RXDX |
Former 10% Owner |
2021-03-16 |
0 |
2021-03-16 |
2,223,022 |
Premium* |
|
|
Design Therapeutics, Inc. |
DSGN |
Former 10% Owner |
2021-03-30 |
0 |
2021-03-30 |
5,114,844 |
Premium* |
|
|
Verve Therapeutics, Inc. |
VERV |
Former 10% Owner |
2021-06-21 |
0 |
2021-06-21 |
984,224 |
Premium* |
|
|
Elevation Oncology, Inc. |
ELEV |
10% Owner |
2021-06-29 |
0 |
2021-06-29 |
2,233,168 |
Premium* |
|
|
Icosavax, Inc. |
ICVX |
Former 10% Owner |
2021-08-02 |
0 |
2021-08-02 |
426,393 |
Premium* |
|
|
Immuneering Corp |
IMRX |
|
2021-08-03 |
0 |
2024-04-01 |
2,895,273 |
Premium* |
|
|
Tyra Biosciences, Inc. |
TYRA |
Former 10% Owner |
2021-09-17 |
0 |
2021-09-17 |
1,069,932 |
Premium* |
|
|
Pyxis Oncology, Inc. |
PYXS |
Former 10% Owner |
2021-10-13 |
0 |
2021-10-13 |
1,118,854 |
Premium* |
|
|
Ventyx Biosciences, Inc. |
VTYX |
10% Owner |
2021-10-25 |
0 |
2021-10-25 |
1,410,303 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
22 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IMRX |
Immuneering Corp |
|
• • • |
2024-04-01 |
4 |
S |
$2.90 |
$1,160,181 |
I/I |
(400,000) |
2,895,273 |
0 |
- |
|
| IMRX |
Immuneering Corp |
|
• • • |
2024-03-15 |
4 |
S |
$2.14 |
$856,400 |
I/I |
(400,000) |
3,295,273 |
0 |
- |
|
| IMRX |
Immuneering Corp |
|
• • • |
2024-03-14 |
4 |
S |
$3.24 |
$1,892,603 |
I/I |
(509,091) |
3,695,273 |
0 |
- |
|
| VTYX |
Ventyx Biosciences, Inc. |
10% Owner |
– – • |
2021-10-25 |
4 |
B |
$16.00 |
$10,000,000 |
I/I |
625,000 |
1,410,303 |
1.5 |
% |
|
| VTYX |
Ventyx Biosciences, Inc. |
10% Owner |
– – • |
2021-10-25 |
4 |
A |
$0.00 |
$0 |
I/I |
785,303 |
785,303 |
0 |
- |
|
| PYXS |
Pyxis Oncology, Inc. |
Former 10% Owner |
– – – |
2021-10-13 |
4 |
B |
$16.00 |
$7,200,000 |
I/I |
450,000 |
1,118,854 |
0.01 |
- |
|
| PYXS |
Pyxis Oncology, Inc. |
Former 10% Owner |
– – – |
2021-10-13 |
4 |
A |
$0.00 |
$0 |
I/I |
668,854 |
668,854 |
0 |
- |
|
| TYRA |
Tyra Biosciences, Inc. |
Former 10% Owner |
– – – |
2021-09-17 |
4 |
B |
$16.00 |
$5,000,000 |
I/I |
312,500 |
1,069,932 |
0.01 |
- |
|
| TYRA |
Tyra Biosciences, Inc. |
Former 10% Owner |
– – – |
2021-09-17 |
4 |
A |
$0.00 |
$0 |
I/I |
757,432 |
757,432 |
0 |
- |
|
| IMRX |
Immuneering Corp |
10% Owner |
– – • |
2021-08-03 |
4 |
B |
$15.00 |
$8,250,000 |
I/I |
550,000 |
2,252,628 |
1.5 |
- |
|
| IMRX |
Immuneering Corp |
10% Owner |
– – • |
2021-08-03 |
4 |
A |
$0.00 |
$0 |
I/I |
1,702,628 |
1,702,628 |
0 |
- |
|
| ICVX |
Icosavax, Inc. |
Former 10% Owner |
– – – |
2021-08-02 |
4 |
A |
$0.00 |
$0 |
I/I |
426,393 |
426,393 |
0 |
- |
|
| ELEV |
Elevation Oncology, Inc. |
10% Owner |
– – • |
2021-06-29 |
4 |
A |
$0.00 |
$0 |
I/I |
1,983,168 |
1,983,168 |
0 |
- |
|
| ELEV |
Elevation Oncology, Inc. |
10% Owner |
– – • |
2021-06-29 |
4 |
B |
$16.00 |
$4,000,000 |
I/I |
250,000 |
2,233,168 |
1.5 |
% |
|
| VERV |
Verve Therapeutics, Inc. |
Former 10% Owner |
– – – |
2021-06-21 |
4 |
B |
$19.00 |
$5,225,000 |
I/I |
275,000 |
984,224 |
0.01 |
- |
|
| VERV |
Verve Therapeutics, Inc. |
Former 10% Owner |
– – – |
2021-06-21 |
4 |
A |
$0.00 |
$0 |
I/I |
709,224 |
709,224 |
0 |
- |
|
| DSGN |
Design Therapeutics, Inc. |
Former 10% Owner |
– – – |
2021-03-30 |
4 |
B |
$20.00 |
$15,000,000 |
I/I |
750,000 |
5,114,844 |
0.01 |
- |
|
| DSGN |
Design Therapeutics, Inc. |
Former 10% Owner |
– – – |
2021-03-30 |
4 |
A |
$0.00 |
$0 |
I/I |
4,364,844 |
4,364,844 |
0 |
- |
|
| RXDX |
Prometheus Biosciences, I... |
Former 10% Owner |
– – – |
2021-03-16 |
4 |
B |
$19.00 |
$7,125,000 |
I/I |
375,000 |
2,223,022 |
0.01 |
% |
|
| RXDX |
Prometheus Biosciences, I... |
Former 10% Owner |
– – – |
2021-03-16 |
4 |
A |
$0.00 |
$0 |
I/I |
1,848,022 |
1,848,022 |
0 |
- |
|
| OLMA |
Olema Pharmaceuticals, In... |
10% Owner |
– – • |
2020-11-23 |
4 |
B |
$19.00 |
$8,075,000 |
I/I |
425,000 |
3,270,544 |
1.5 |
- |
|
| OLMA |
Olema Pharmaceuticals, In... |
10% Owner |
– – • |
2020-11-23 |
4 |
A |
$0.00 |
$0 |
I/I |
2,845,544 |
2,845,544 |
0 |
- |
|
22 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
